Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Revenue

Avadel Pharmaceuticals had revenue of $55.14M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $27.18M. In the year 2023, Avadel Pharmaceuticals had annual revenue of $27.96M.

• Revenue (ttm): $55.14M
• Revenue Growth: n/a
• P/S Ratio: 24.21
• Revenue / Employee: $358,058
• Employees: 154
• Market Cap: 1.34B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	27.96M	-	-
Dec 31, 2022	0	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	22.33M	-36.88M	-62.28%
Dec 31, 2019	59.22M	-44.05M	-42.66%
Dec 31, 2018	103.27M	-69.98M	-40.39%
Dec 31, 2017	173.25M	23.00M	15.31%
Dec 31, 2016	150.25M	-22.76M	-13.16%
Dec 31, 2015	173.01M	158.03M	1,055.32%
Dec 31, 2014	14.98M	10.80M	258.34%
Dec 31, 2013	4.18M	-3.36M	-44.53%
Dec 31, 2012	7.53M	-25.07M	-76.89%
Dec 31, 2011	32.60M	-4.49M	-12.12%
Dec 31, 2010	37.09M	-5.02M	-11.93%
Dec 31, 2009	42.12M	3.50M	9.06%
Dec 31, 2008	38.62M	1.97M	5.36%
Dec 31, 2007	36.65M	13.63M	59.23%
Dec 31, 2006	23.02M	-578.00K	-2.45%
Dec 31, 2005	23.60M	-31.81M	-57.41%
Dec 31, 2004	55.41M	30.24M	120.17%
Dec 31, 2003	25.17M	6.76M	36.73%
Dec 31, 2002	18.41M	5.32M	40.64%
Dec 31, 2001	13.09M	2.19M	20.04%
Dec 31, 2000	10.90M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.